Corteva, Inc. $CTVA Holdings Boosted by Metis Global Partners LLC

Metis Global Partners LLC raised its stake in Corteva, Inc. (NYSE:CTVAFree Report) by 20.7% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 107,570 shares of the company’s stock after acquiring an additional 18,484 shares during the period. Metis Global Partners LLC’s holdings in Corteva were worth $7,275,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. NORTHSTAR ASSET MANAGEMENT Co boosted its position in Corteva by 2.2% during the 2nd quarter. NORTHSTAR ASSET MANAGEMENT Co now owns 6,940 shares of the company’s stock valued at $517,000 after purchasing an additional 150 shares during the period. Empirical Finance LLC lifted its stake in Corteva by 0.6% in the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after buying an additional 153 shares during the last quarter. Carnegie Investment Counsel boosted its holdings in shares of Corteva by 3.0% during the second quarter. Carnegie Investment Counsel now owns 5,607 shares of the company’s stock valued at $418,000 after acquiring an additional 164 shares during the period. United Community Bank grew its position in shares of Corteva by 10.5% during the third quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after acquiring an additional 176 shares during the last quarter. Finally, Curat Global LLC increased its holdings in shares of Corteva by 93.7% in the 2nd quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after acquiring an additional 179 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CTVA. CICC Research boosted their target price on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Wednesday. Bank of America boosted their price objective on Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. Oppenheimer set a $86.00 price objective on Corteva in a report on Thursday, February 5th. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research note on Thursday, January 22nd. Finally, UBS Group cut Corteva from a “buy” rating to a “hold” rating in a research note on Monday. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus price target of $82.20.

Check Out Our Latest Stock Analysis on CTVA

Corteva Stock Down 1.8%

Shares of CTVA stock opened at $73.99 on Friday. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The business’s fifty day moving average is $69.49 and its 200-day moving average is $68.45. The stock has a market cap of $50.00 billion, a PE ratio of 46.83, a price-to-earnings-growth ratio of 2.57 and a beta of 0.75.

Corteva (NYSE:CTVAGet Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s quarterly revenue was down 1.7% on a year-over-year basis. During the same quarter last year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a $0.18 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.0%. Corteva’s payout ratio is currently 45.57%.

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Recommended Stories

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.